[tdc_zone][vc_row full_width=”stretch_row” el_class=”td-travel-header td-stretch-content” row_divider_top=”” content_align_vertical=”content-vert-top” tdc_css=”eyJhbGwiOnsiYmFja2dyb3VuZC1pbWFnZSI6InVybChcImh0dHBzOi8vd3d3LmRpd291LmNvbS93cC1jb250ZW50L3VwbG9hZHMvMjAxOS8wNS9hZHZhbmNlLWluLWJyZWFrdGhyb3VnaC1jYW5jZXItdHJlYXRtZW50LWVsaW1pbmF0ZXMtc2VyaW91cy1zaWRlLWVmZmVjdHMuanBnXCIpIiwiYmFja2dyb3VuZC1wb3NpdGlvbiI6ImNlbnRlciBjZW50ZXIiLCJkaXNwbGF5IjoiIn19″][vc_column][/vc_column][/vc_row][vc_row el_class=”td-Biotech-News”][vc_column]

[/vc_column][/vc_row][vc_row][vc_column]
- Advertisement -
[/vc_column][/vc_row][vc_row][vc_column]

Biotechnology to reduce methane emissions from cattle – UQ News – uq.edu.au

Methane emissions could be substantially cut through a $7.5-million project to develop slow-release biopolymer technology for cattle containing a gas-reducing bioactive.The University of Queensland...

Stem cells can repair Parkinson’s-damaged circuits in mouse brains

Credit: UW-Madison MADISON, Wis. — The mature brain is infamously bad at repairing itself following damage like...

Cerba Healthcare to acquire Canadian contract research laboratory Cirion Biopharma Research to expand bioanalytical capabilities and shorten time-to-deploy complex clinical trials

Cerba HealthCare, a leading global player in medical diagnosis, today announced it has acquired CIRION BIOPHARMA RESEARCH INC (CIRION), a Canadian-controlled private company highly...
[vc_empty_space height=”2px”][/vc_column][/vc_row][vc_row][vc_column]

Rentschler Biopharma Focuses on Reducing Timelines with Process Intensification

Rentschler Biopharma sped up the cell culture step of its biomanufacturing process by 35% by “seeding” the bioreactor with a larger number of cells....

Puma Biotechnology Announces $10 Million Private Placement – businesswire.com

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (the Company) (Nasdaq: PBYI), a biopharmaceutical company, announced that it has entered into a securities purchase agreement with Alan...

Pancreatic Cancer Drug Resistance Pathways Identified

Scientists at Cold Spring Harbor Laboratory (CSHL) say they have found a way to tackle the problem of drug resistance and stop the growth...
[/vc_column][/vc_row][vc_row][vc_column width=”2/3″]

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today...

Stem cell implants aim to restore dopamine in Parkinson’s disease

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed...
[/vc_column][vc_column width=”1/3″]

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today...

Stem cell implants aim to restore dopamine in Parkinson’s disease

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed...

Small molecule targets glioblastoma oncogene in preclinical studies

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed...
[/vc_column][/vc_row][vc_row][vc_column]

more new items

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today...

Stem cell implants aim to restore dopamine in Parkinson’s disease

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed...

Small molecule targets glioblastoma oncogene in preclinical studies

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed...
[/vc_column][/vc_row][/tdc_zone]